MGC Pharma in collaboration with HempStreet launches ArtemiC

HempStreet, India's first research to retail medicinal cannabis venture, has launched 'ArtemiC,' a nutraceutical mouth spray to speed up recovery for patients with severe Covid-19 symptoms. ArtemiC has been launched in collaboration with MGC Pharma, a company with which HempStreet announced a partnership earlier this year. Headquartered in the UK, MGC Pharma is a pharmaceuticals company working on polyherbal formulations based on cannabis and other phytopharmaceuticals. Through this collaboration it aims to create and bring to market phytopharma products to tackle mass ailments. With ArtemiC, the companies expect to reduce the symptoms of long Covid-19, which still affects more than 15 million people in India. ArtemiC, includes four natural-based ingredients consisting of curcumin, boswellia serrata, artemisinin and vitamin C. ArtemiC Rescue and ArtemiC Support are the two variations of this product that will be available via medical practitioners and leading pharmacies. ArtemiC Rescue is an adjunctive treatment for the symptoms of Covid-19, whereas ArtemiC Support is a daily supplement that does not contain artemisinin. According to the double-blind, placebo-controlled clinical research findings, ArtemiC may minimize the severity of symptoms of Covid-19. In addition, the clinical trial demonstrated a significant reduction in one of the primary inflammatory markers related to Covid-19, C-reactive protein (CRP), an acute inflammatory protein that increases up to 1,000-fold at sites of infection or inflammation. Abhishek Mohan, founder & CEO of HempStreet, said, " An observational open-label controlled clinical trial of ArtemiC, showed that the formulation demonstrated its efficacy in treating patients with severe Covid-19 for the first time. An estimated 15 million people in India are said to be suffering from

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!